# APRISO

NDC: 65649-103
Generic name: mesalamine
Labeler / Manufacturer: Salix Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, EXTENDED RELEASE
Routes: ORAL
Marketing started: 20081031

FDA application: NDA022301

## Active ingredients

- MESALAMINE: 375 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65649-103"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65649-103
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=7951139c-b271-45a4-b523-34b23800917b